跳至主要内容
临床试验/JPRN-UMIN000007390
JPRN-UMIN000007390已完成2 期

Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-R11: Multi-center Phase II Study of the efficacy and the safety in the induction chemotherapy containing fludarabine for children with the first bone marrow relapse and induction failure of acute myeloid leukemia. - AML-R11

Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)0 个研究点目标入组 50 人开始时间: 2012年3月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2years-old 至 20years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. isolated extramedullary relapse 2. history of allogeneic stem cell transplantation 3. history of FLAG therapy 4. any complication listed below; active or unmanageable infectious disease, severe CNS bleeding(example; CTCAE Ver. 4.0; grade 3 or more, uncontrolled DM, severe mental abnormalities, heart diseases, hemophillia, autoimmune diseases 5. pregnancy 6. history of congenital or acquirede immunodeficiency 7. contraindication of cytosine arbinoside or idarubicin 8. administration of anti-cancer agent within 14 days of the enrollment 9. unusual treatment schedule or intermission in the first induction chemotherapy for AML because of personal request etc 10. any inappropriate status judged by physician

研究者

发起方
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)

相似试验

已完成
2 期
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) ALL-B12: A Multi-Center Phase II/III Study in Children with Newly Diagnosed B-cell Precursor Acute Lymphoblastic LeukemiaB cell precursor Acute Lymphoblastic Leukemia
JPRN-UMIN000009339Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)1,940
已完成
2 期
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-D05: Phase II Study of Risk Stratified Multi-drug Chemotherapy on Down Syndrome with Newly diagnosed Childhood Acute Myeloid LeukemiaAcute myeloid Leukemia Myelodysplastic syndrome
JPRN-UMIN000000989Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG)73
已完成
不适用
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) CML-08: A Multi-Center Observational Study for Children with Chronic Phase of Chronic Myeloid LeukemiaChronic Phase of Chronic Myeloid Leukemia (CML) in children
JPRN-UMIN000002581Japanese Pediatric Leukemia/Lymphoma Study Group22
招募中
2 期
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) ALL-T11 and Japan Adult Leukemia Study Group (JALSG) T-ALL-211-U ALL-T11: A Multi-Center Phase II Study in Children and Adolescence with Newly Diagnosed T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic Leukemia
JPRN-UMIN000006851Japanese Pediatric Leukemia/Lymphoma Study Group147
已完成
2 期
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-P05: A Multi-Center Phase II Study in Children with Newly Diagnosed Acute Promyelocytic Leukemia (APL)Acute promyelocytic leukemia
JPRN-UMIN000000645Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)44